Journal of Clinical and Aesthetic Dermatology

JUN 2017

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link: http://jcadonline.epubxp.com/i/839245

Contents of this Issue

Navigation

Page 23 of 63

24 JCAD journal of clinical and aesthetic dermatology June 2017 • Volume 10 • Number 6 being used sometimes, often, or always by 33.3 percent of the ETR cohort and by 32.5 percent of the PPR cohort. The most common scenario for the use of a topical prescription agent or an oral antibiotic was to manage a rosacea flare-up (Figures 4A and 4B). Other commonly used treatments included sun protection, used by 79.2 percent and 79.6 percent of participants in the ETR and PPR cohorts, respectively, and non- prescription facial cleansers, used by 45.0 percent in the ETR cohort and 61.3 percent in the PPR cohort (p=0.0057) (Table 3). Fewer than half of participants were satisfied with their prescription treatments, and slightly more than half were satisfied with OTC agents. The proportion of those who were satisfied or very satisfied with topical prescription treatments was 43.7 percent, with oral antibiotics was 48.1 percent, and with OTC agents was 51.2 percent (Figure 5). For those participants who reported being dissatisfied or very dissatisfied with one or more of their treatments, the most common reasons for dissatisfaction were that the agent did not meet the respondent's expectations for treatment of signs or symptoms, that the treatment was too expensive, and that it took too long to achieve noticeable results. Dissatisfaction commonly resulted in participants not using the treatment as specified or skipping treatment (43.0%) (Table 4). DISCUSSION The results of this survey indicate that there is a considerable burden of illness associated with rosacea, despite the survey participants with ETR and PPR reporting that the severity of their rosacea was mild or moderate. Participants reported a variety of bothersome rosacea-associated signs, including facial erythema and telangiectasia, and symptoms, such as cutaneous burning and/or stinging (in both the ETR and PPR cohorts), and papules and pustules (primarily in the PPR cohort). This array of bothersome clinical manifestations was in line with the classical definitions for ETR and PPR. 4 To manage these signs and symptoms during rosacea flare- ups, participants employed an array of coping and avoidance mechanisms, including stress O R I G I N A L R E S E A R C h Figure 2B. Most bothersome symptoms of rosacea reported by study participants. *p<0.01; †p<0.001; ‡p<0.0001 ETR=erythematotelangiectatic rosacea; PPR=papulopustular rosacea

Articles in this issue

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - JUN 2017